
Sign up to save your podcasts
Or


The big beta-blocker story from ESC, dual pathway therapy with aspirin and OAC, stopping OAC after successful AF ablation, and DANCAVAS II trial are the topics John Mandrola, MD, discusses on this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I Listener Feedback
This Week in Cardiology Podcast – August 29 https://www.medscape.com/viewarticle/1002877
II The Big Beta-blocker Story from ESC
Beta-Blockers Post-MI: A Clear Clinical Message https://www.medscape.com/viewarticle/beta-blockers-post-mi-clear-clinical-message-2025a1000mz0
III Aspirin and OAC Combination Clearly Dangerous
Aspirin Plus Oral Anticoagulants Raises Mortality, Bleeding https://www.medscape.com/viewarticle/aspirin-plus-oral-anticoagulants-raises-mortality-bleeding-2025a1000nam
IV Stop or Continue OAC after Successful AF Ablation
V DANCAVAS II Trial
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]
By Medscape4.9
856856 ratings
The big beta-blocker story from ESC, dual pathway therapy with aspirin and OAC, stopping OAC after successful AF ablation, and DANCAVAS II trial are the topics John Mandrola, MD, discusses on this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I Listener Feedback
This Week in Cardiology Podcast – August 29 https://www.medscape.com/viewarticle/1002877
II The Big Beta-blocker Story from ESC
Beta-Blockers Post-MI: A Clear Clinical Message https://www.medscape.com/viewarticle/beta-blockers-post-mi-clear-clinical-message-2025a1000mz0
III Aspirin and OAC Combination Clearly Dangerous
Aspirin Plus Oral Anticoagulants Raises Mortality, Bleeding https://www.medscape.com/viewarticle/aspirin-plus-oral-anticoagulants-raises-mortality-bleeding-2025a1000nam
IV Stop or Continue OAC after Successful AF Ablation
V DANCAVAS II Trial
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]

320 Listeners

695 Listeners

499 Listeners

166 Listeners

13 Listeners

16 Listeners

301 Listeners

3,360 Listeners

139 Listeners

1,142 Listeners

62 Listeners

40 Listeners

516 Listeners

368 Listeners

61 Listeners

27 Listeners

9 Listeners

427 Listeners

369 Listeners

274 Listeners